European Case Law Identifier: | ECLI:EP:BA:2010:T038608.20101122 | ||||||||
---|---|---|---|---|---|---|---|---|---|
Date of decision: | 22 November 2010 | ||||||||
Case number: | T 0386/08 | ||||||||
Application number: | 01913081.4 | ||||||||
IPC class: | C07K 16/18 | ||||||||
Language of proceedings: | EN | ||||||||
Distribution: | C | ||||||||
Download and more information: |
|
||||||||
Title of application: | Humanized antibodies that sequester amyloid beta peptide | ||||||||
Applicant name: | Washington University St. Louis, et al. | ||||||||
Opponent name: | Neuralab Ltd. | ||||||||
Board: | 3.3.04 | ||||||||
Headnote: | - | ||||||||
Relevant legal provisions: | |||||||||
Keywords: | "Main request - added matter (yes); Auxiliary requst I - clarity (no); Auxiliary request II - added matter, extension of scope (no); clarity, enablement, novelty, inventive step (yes)" |
||||||||
Catchwords: |
- |
||||||||
Cited decisions: |
|
||||||||
Citing decisions: |
|
Source: http://www.epo.org/law-practice/case-law-appeals/recent/t080386eu1.html
Date retrieved: 17 May 2021